🇺🇸 FDA
Patent

US 11136562

Conditionally active heterodimeric polypeptides and methods of use thereof

granted A61KA61K2039/5156A61K2039/5158

Quick answer

US patent 11136562 (Conditionally active heterodimeric polypeptides and methods of use thereof) held by The Regents of the University of California expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/5156, A61K2039/5158, A61K35/17, A61K38/00